Evolutionary particulars of COVID-19 in elderly patients
Закрыть
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
88 0
Căutarea după subiecte
similare conform CZU
616.98:578.834.1]-053.9 (1)
Инфекционные заболевания. Инфекционные лихорадки (280)
Вирусология (169)
SM ISO690:2012
POPA, Ana; NEGARĂ, Anatolie; ŞORIC, Gabriela; POPESCU, Ana. Evolutionary particulars of COVID-19 in elderly patients. In: Moldovan Medical Journal. 2020, nr. 6(63), pp. 21-24. ISSN 2537-6373.
10.5281/zenodo.4028371
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Moldovan Medical Journal
Numărul 6(63) / 2020 / ISSN 2537-6373 /ISSNe 2537-6381

Evolutionary particulars of COVID-19 in elderly patients


DOI: 10.5281/zenodo.4028371
CZU: 616.98:578.834.1]-053.9
Pag. 21-24

Popa Ana, Negară Anatolie, Şoric Gabriela, Popescu Ana
 
”Nicolae Testemițanu” State University of Medicine and Pharmacy
 
Disponibil în IBN: 9 decembrie 2020


Rezumat

Background: The new SARS-CoV-2 coronavirus affects a large number of people worldwide, and the elderly are particularly affected because of their vulnerability. Thus, the elderly patients and those with comorbidities have an increased risk of developing a severe disease and show an increased mortality rate. Although they may show mild symptoms of illness and low-grade fever in the early days, they may worsen clinically rapidly, requiring ongoing monitoring. Material and methods: The prospective study was performed on a group of 96 patients (mean age 61.41 ± 3.42 years), with a predominance of men, hospitalized in the Holy Trinity Hospital of Chisinau who met the clinical case definition and were laboratory case-confirmed with COVID-19. Patients were clinically and paraclinically investigated according to the WHO Provisional National Clinical Protocol for COVID-19 infection reporting. The data were statistically processed by the Statistics 10 program. Results: Of the 96 patients with COVID-19, 85 (88.54%) reported at least one had a comorbidity. The prevalence of comorbidities was the following: chronic coronary syndromes (40.1%), hypertension (39.7%), diabetes (16.04%), chronic obstructive pulmonary disease (17.3%), malignancy (13.04%), cerebrovascular disease (10.6%), chronic kidney disease (4.3%) and viral hepatitis B (1.8%). Severe cases of the disease were revealed – 58, medium severity – 38 cases. All critical cases resulting in death (7.29%) showed comorbidities with respiratory symptoms, as well as with the onset of acute respiratory failure. Conclusions: The elderly, male gender and the presence of comorbidities in patients with COVID-19 determine the severe course of the disease and an increased mortality rate.

Cuvinte-cheie
COVID-19, elderly, mortality